Max Healthcare Institute Ltd Financials: Quarterly Results
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
Profit and loss statement
CAGR in 10 years
Sales
13.39%
Operating Profit
64.21%
PAT
37.89%
Mar 2024 (Cr.) | Mar 2023 (Cr.) | Mar 2022 (Cr.) | Mar 2021 (Cr.) | Mar 2020 (Cr.) | ||
---|---|---|---|---|---|---|
SALES | 2,446.01 | 1,997.31 | 1,855.31 | 1,079.68 | 59.26 | |
OPERATING PROFIT | 762.04 | 584.09 | 443.26 | -49.77 | -5.97 | |
OP PROFIT MARGIN | 31.15 | 29.24 | 23.89 | -4.61 | -10.07 | |
INTEREST | 51.66 | 51.91 | 58.93 | 112.45 | 59.99 | |
PROFIT AFTER TAX | 687.26 | 694.31 | 331.52 | -164.45 | -2.96 | |
CASH PROFIT | 803.90 | 808.65 | 435.57 | -65.82 | 0.39 | |
EPS | 7.07 | 7.15 | 3.42 | -1.70 | -0.06 |
Balance sheet
CAGR in 10 years
Net Worth
25.26%
Debt
4.57%
Gross Block
26.21%
Mar 2024 (Cr.) | Mar 2023 (Cr.) | Mar 2022 (Cr.) | Mar 2021 (Cr.) | Mar 2020 (Cr.) | ||
---|---|---|---|---|---|---|
EQUITY | 971.91 | 970.92 | 969.61 | 965.95 | 537.24 | |
RESERVE SURPLUS | 6,708.85 | 6,071.14 | 5,341.77 | 4,973.48 | 2,337.84 | |
TOT DEBTS | 442.62 | 533.52 | 555.52 | 479.57 | 657.82 | |
GROSS BLOCK | 5,131.21 | 4,812.94 | 4,714.85 | 3,079.39 | 105.08 | |
CAPITAL WORK IN PROGRESS | 235.04 | 102.85 | 60.25 | 8.34 | 0 | |
CASH LIQUID INVESTMENT | 720.04 | 1,231.46 | 386.51 | 610.99 | 65.76 | |
NET WORKING CAPITAL | 107.77 | 613.47 | -209.30 | 258.78 | 643.50 | |
CURRENT ASSETS | 1,098.40 | 1,502.35 | 752.61 | 1,018.84 | 663.50 | |
CURRENT LIABILITIES | 990.63 | 888.88 | 961.91 | 760.06 | 20 |
Quarterly Result
Sep 2024 (Cr.) | Jun 2024 (Cr.) | Mar 2024 (Cr.) | Dec 2023 (Cr.) | Sep 2023 (Cr.) | ||
---|---|---|---|---|---|---|
SALES | 686.11 | 621.39 | 610.11 | 590.75 | 596.87 | |
GROSS PROFIT | 350.33 | 233.30 | 322.46 | 232.83 | 237.65 | |
GROSS PROFIT MARGINS | 80.24 | 80.66 | 81.57 | 82.37 | 81.85 | |
OPERATING PROFIT | 224.67 | 198.07 | 199.43 | 200.15 | 202.83 | |
OP PROFIT MARGIN | 47.51 | 33.92 | 50.05 | 36.11 | 37.40 | |
INTEREST | 7.85 | 7.64 | 14.74 | 10 | 13.22 | |
PROFIT AFTER TAX | 231.30 | 154.14 | 241.77 | 158.12 | 161.31 | |
CASH PROFIT | 263.48 | 184.28 | 273.61 | 187.62 | 188.93 | |
EPS | 2 | 1.59 | 2.49 | 1.63 | 1.66 |
Ratio
CAGR in 10 years
Net Worth
25.26%
Debt
4.57%
Gross Block
26.21%
Mar 2024 (%) | Mar 2023 (%) | Mar 2022 (%) | Mar 2021 (%) | Mar 2020 (%) | ||
---|---|---|---|---|---|---|
PE | 116.02 | 61.67 | 101.46 | -121.03 | 0 | |
P BV | 10.38 | 6.08 | 5.33 | 3.35 | 0 | |
MCAP SALES | 32.60 | 21.44 | 18.13 | 18.43 | 0 | |
ASSET TURNOVER | 0.31 | 0.28 | 0.28 | 0.22 | 0.02 | |
EV/EBITDA | 76.90 | 57.84 | 59.16 | 348.46 | 0 | |
DEBT/EQUITY | 0.07 | 0.08 | 0.08 | 0.13 | 0.25 | |
ROE | 9.34 | 10.40 | 5.41 | 0 | 0 | |
ROCE | 11.64 | 8.49 | 6.89 | 0 | 0 |